Clincosm LogoSign in Get a demo

Alter-MAI: Alternative Care in Patients With Auto-Immune Diseases

Sponsor
University Hospital, Limoges (Other)
Overall Status
Completed
CT.gov ID
NCT04094259
Collaborator
(none)
121
Enrollment
1
Location
26.7
Actual Duration (Months)
4.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients followed in Internal Medicine bring together favorable conditions for the use of alternative medicines. While some are recognized for their benefits, some can, on the contrary, harm the patient. It is therefore proposed to make a complete descriptive inventory of these practices, through an anonymized questionnaire. The main objective is the evaluation of the proportion of the use of alternative medicines in patients with in the department of Internal Medicine A

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaire.

Detailed Description

Patients followed in Internal Medicine department bring together favorable conditions for the use of alternative medicines. While some are recognized for their benefits, some can, on the contrary, harm the patient. It is therefore proposed to make a complete descriptive inventory of these practices, through an anonymized questionnaire. The main objective is the evaluation of the proportion of the use of alternative medicines in patients with autoimmune diseases in the department of Internal Medicine .

At all times alternative medicine has existed. Internal Medicine deals with rare autoimmune diseases, of which there is not always a cure. Even when the treatment is optimal, there are often subjective complaints.Patients followed in Internal Medicine therefore have favorable conditions for the use of alternative medicines. While some are recognized for their benefits, some can, on the contrary, harm the patient. It is therefore proposed to make a complete descriptive inventory of these practices, through an anonymized questionnaire. This information will make it possible to target the patient's needs, and to be able to offer alternative medicines that are better focused, without calling into question their conventional treatment

Study Design

Study Type:
Observational
Actual Enrollment :
121 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Proportion of the Use of Medicines and Alternative Care in Patients With Auto-Immune Diseases Alter-MAI
Actual Study Start Date :
Sep 9, 2019
Actual Primary Completion Date :
Dec 1, 2021
Actual Study Completion Date :
Dec 1, 2021

Outcome Measures

Primary Outcome Measures

  1. The number of patients using alternative medicine. [At day 1]

    Counting the number of patients using alternative medicine.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:

  • Patient with systemic lupus erythematosus (ARA and/or SLICC criteria) OR with primary Sjögren's syndrome (revised Americano European criteria) OR with systemic scleroderma (ACR/EULAR 2012 criteria)

  • Patient with signed consent

Exclusion criteria:

  • Patients deprived of their liberty

  • Minors and adults subject to legal protection measures

  • Patients subject to a justice safeguard measure

  • Patient unable to understand or adhere to the protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 Médecin Interne A Limoges France

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT04094259
Other Study ID Numbers:
  • 87RI19-0020 (ALTER-MAI)
First Posted:
Sep 18, 2019
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Immune System Diseases
Autoimmune Diseases

Study Results

No Results Posted as of Aug 9, 2022